Peripheral Vascular Disease
📧 Sign up to get email alerts when something new happens for Peripheral Vascular Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-03EMA Authorised: Clopidogrel Zentiva (previously Clopidogrel Winthrop) (clopidogrel) — Zentiva k.s.
Authorisation granted for Clopidogrel Zentiva (clopidogrel), expanding or confirming its availability for stroke, peripheral vascular diseas…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
A Boston Scientific-sponsored registry evaluating real-world use of a drug-eluting device for peripheral vascular lesions; the study is curr…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: ENhancing Exercise With LIGHT to Improve Functioning in PAD [NA]
A Northwestern University-led clinical trial is testing whether a LIGHT-based exercise program can improve function in people with periphera…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication [Phase 1]
Phase 1 clinical trial evaluating ATLAS Therapy and its effect on nitric oxide bioavailability in patients with intermittent claudication du…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Effects of Different Compression Pressure Levels on Peripheral Circulation After Surgery [NA]
A completed clinical trial evaluating the effects of different compression pressure levels on peripheral circulation after surgery.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: EVERO Drug-coated Balloon (DCB) Randomized Trial [NA]
A registered randomized trial of the EVERO drug-coated balloon for peripheral vascular disease is currently recruiting.
-
CLINICAL_TRIALS other · 2026-04-01Clinical Trial Update: Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 3 [NA]
An ongoing clinical trial is evaluating whether exercise training improves vascular dysfunction in individuals with mental health disorders,…
-
EMA approval · 2026-03-31EMA Authorised: Brilique (ticagrelor) — AstraZeneca AB
EMA authorised Brilique (ticagrelor) for use in acute coronary syndrome and peripheral vascular disease, with AstraZeneca AB as the marketin…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE) [Phase 3]
Phase 3 clinical trial evaluating automated CO2 injection during peripheral vascular interventions to spare iodinated contrast and prevent m…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1 [NA]
A clinical trial sponsored by Virginia Commonwealth University is evaluating whether exercise training can improve vascular dysfunction in i…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD [NA]
This clinical trial update notes the completion of a study examining the role of microRNA-210 in regulating oxidative stress in patients wit…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions [Phase 3]
A Phase 3 trial evaluating screening for high on-treatment platelet reactivity (HPR) in patients undergoing lower-extremity arterial endovas…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38) [NA]
Clinical trial evaluating single versus dual antiplatelet therapy in elderly or high-bleeding-risk patients undergoing percutaneous interven…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Peripheral Nerve Blocks for Above-the-knee Amputations [Phase 4]
Phase 4 trial update reporting completed results for peripheral nerve blocks used in above-the-knee amputation procedures.
-
EMA approval · 2025-12-12EMA Authorised: Clopidogrel Viatris (previously Clopidogrel Taw Pharma) (clopidogrel besilate) — Viatris Limited
The EMA has authorized Clopidogrel Viatris (clopidogrel besilate) for use in preventing thrombotic events in patients with peripheral vascul…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) [Phase 4]
A Phase 4 trial assessing dual antiplatelet therapy in patients with multi-vessel coronary disease has completed.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2 [NA]
A trial recruitment update for Study 2 examining whether exercise training improves vascular dysfunction in adults with mental health disord…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Virtual Diabetes Group Visits Across Health Systems [Phase 2]
Phase 2 clinical trial evaluating virtual diabetes group visits across health systems for adults with type 2 diabetes and hypertension, with…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Brain Vascular and Neurocognitive Health [NA]
This clinical trial update reports the completion of a study focused on brain vascular health and neurocognitive outcomes, including Alzheim…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease [EARLY_Phase 1]
An early-phase clinical trial evaluating whether activating Nrf2 improves macrovascular and microvascular function, leg performance, and wal…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease [NA]
This clinical trial update describes LEAP therapy (Leg Exercise Assistive Paddling) for peripheral artery disease and notes that recruitment…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation [Phase 1]
Phase 1 clinical and histological analysis of mesenchymal stem cells in amputation due to ischemia and peripheral arterial disease, with the…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform
This document reports a post-marketing clinical follow-up study evaluating the safety, performance, and usability of Balt Extrusion's EVIDEN…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy [NA]
This clinical trial update describes a randomized controlled trial evaluating alert-based computerized decision support for patients with pe…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Implementation of Telemedicine for Patient With Lower Extremity Wounds [NA]
Clinical trial update indicates completion of a study evaluating telemedicine for managing lower extremity wounds in patients with periphera…